- Events
03/06/2026
TransCure bioServices will attend the International HBV Meeting 2026, taking place from September 6 to 10 in Singapore.
Maxence Cornut, PhD will be presenting a poster showcasing TransCure bioServices’ latest work on modeling HBV infection and treatment in humanized liver mice.
The study demonstrates the ability of humanized liver TK-NOG mice to support sustained HBV infection and benchmark antiviral response to entecavir, highlighting their potential for the preclinical evaluation of novel HBV therapies.
Maxence will also be available throughout the meeting to discuss how our advanced humanized mouse models can support translational research in infectious diseases and liver diseases.
Our humanized mouse models enable researchers to investigate host-pathogen interactions, evaluate innovative antiviral strategies, and generate robust preclinical data to support therapeutic development.
Planning to attend the HBV Meeting?
Join us at Poster Session II
📅 Tuesday, September 8, 2026
🕠 5:30–7:00 PM
Come discover our latest data and discuss your HBV research with us.